Human Genome Sciences announces plan to lay off 114

Rockville firm was acquired by GlaxoSmithKline

September 05, 2012|By Jamie Smith Hopkins, The Baltimore Sun

Rockville-based Human Genome Sciences has warned state regulators that it plans to cut 114 jobs beginning in October, three months after striking a deal to be acquired by GlaxoSmithKline.

Human Genome, which employs about 1,000 people in Rockville, could not be reached for comment Wednesday. But it told the state Department of Labor, Licensing and Regulation that the layoffs — to start Oct. 30 — were part of an internal restructuring.

GlaxoSmithKline, a London pharmaceutical firm, also could not immediately be reached for comment.

jhopkins@baltsun.com

Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.